BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23108983)

  • 1. Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.
    Qiu F; Bian W; Li J; Ge Z
    Biomed Chromatogr; 2013 May; 27(5):615-21. PubMed ID: 23108983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
    Rais R; Zhao M; He P; Xu L; Deeken JF; Rudek MA
    Biomed Chromatogr; 2012 Nov; 26(11):1315-24. PubMed ID: 22259028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of subutinib and its active metabolite in human plasma by LC-MS/MS: Application to pharmacokinetic study.
    Ding LK; Yang L; Chen SN; Li JK; Wen AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():22-6. PubMed ID: 26253807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of sunitinib and its active metabolite, N-desethyl sunitinib in mouse plasma and tissues by UPLC-MS/MS: assay development and application to pharmacokinetic and tissue distribution studies.
    Chen X; Wang Z; Liu M; Liao M; Wang X; Du H; Chen J; Yao M; Li Q
    Biomed Chromatogr; 2015 May; 29(5):679-88. PubMed ID: 25294592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a sensitive, simple, and rapid method for simultaneous quantitation of atorvastatin and its acid and lactone metabolites by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
    Macwan JS; Ionita IA; Dostalek M; Akhlaghi F
    Anal Bioanal Chem; 2011 Apr; 400(2):423-33. PubMed ID: 21359569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of apatinib and its four major metabolites in human plasma using liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study.
    Ding J; Chen X; Dai X; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():108-15. PubMed ID: 22503745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Minkin P; Zhao M; Chen Z; Ouwerkerk J; Gelderblom H; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):84-8. PubMed ID: 18823825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastasized renal cell carcinoma. Measurement of plasma levels of the tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib].
    Keil C; Götze L; Olbert P; Hofmann R; Nockher WA; Hegele A
    Urologe A; 2015 Jun; 54(6):811-8. PubMed ID: 25503897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous UFLC-ESI-MS/MS determination of piperine and piperlonguminine in rat plasma after oral administration of alkaloids from Piper longum L.: application to pharmacokinetic studies in rats.
    Liu J; Bi Y; Luo R; Wu X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2885-90. PubMed ID: 21903488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study.
    Rodamer M; Elsinghorst PW; Kinzig M; Gütschow M; Sörgel F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):695-706. PubMed ID: 21367676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
    Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
    Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an HPLC-UV-visible method for sunitinib quantification in human plasma.
    Blanchet B; Saboureau C; Benichou AS; Billemont B; Taieb F; Ropert S; Dauphin A; Goldwasser F; Tod M
    Clin Chim Acta; 2009 Jun; 404(2):134-9. PubMed ID: 19341717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of SYL-1119 and SYL-1119-P in rat plasma using HPLC coupled with tandem mass spectrometry.
    Yang S; Hu J; Li Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():193-8. PubMed ID: 24355213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination and pharmacokinetic study of the novel anti-tumor candidate drug DG-7 in rat plasma by liquid chromatography-tandem mass spectrometry.
    Li J; Liu DD; Ke Y; Guo F; Ding XM; Wang SL; Chen Y; Liu HM; Su YQ; Nan YY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():14-8. PubMed ID: 24780702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of febuxostat and its three active metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study in Chinese healthy volunteers.
    Wu Y; Mao Z; Liu Y; Wang X; Di X
    J Pharm Biomed Anal; 2015 Oct; 114():216-21. PubMed ID: 26072013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of glimepiride and pioglitazone in human plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study.
    Ni XJ; Wang ZZ; Shang DW; Zhang M; Hu JQ; Qiu C; Wen YG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():247-52. PubMed ID: 24835512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of flumatinib and its two major metabolites in plasma of chronic myelogenous leukemia patients by liquid chromatography-tandem mass spectrometry.
    Yang Y; Liu K; Zhong D; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():25-30. PubMed ID: 22472641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous analysis of oral anticancer drugs for renal cell carcinoma in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.
    Takasaki S; Tanaka M; Kikuchi M; Maekawa M; Kawasaki Y; Ito A; Arai Y; Yamaguchi H; Mano N
    Biomed Chromatogr; 2018 Jun; 32(6):e4184. PubMed ID: 29283445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.
    Marangon E; Buzzo M; Posocco B; Gagno S; Zanchetta M; Iacuzzi V; Poetto AS; Guardascione M; Giodini L; Toffoli G
    J Pharm Biomed Anal; 2020 Feb; 179():112949. PubMed ID: 31784210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.